Literature DB >> 23243266

AKI associated with synthetic cannabinoids: a case series.

Gautam Kantilal Bhanushali1, Gaurav Jain, Huma Fatima, Leah J Leisch, Denyse Thornley-Brown.   

Abstract

SPICE, or K2, encompasses preparations of synthetic cannabinoids marketed as incense products, bath additives, and air fresheners and used for recreational purposes. These preparations are usually smoked for their cannabis-like effects and do not appear on routine urine toxicology screens. We report four cases of oliguric AKI associated with SPICE use in previously healthy men. All showed improvement in renal function without need for renal replacement therapy. Renal biopsy, performed in three of the patients, revealed acute tubular necrosis. The close temporal and geographic associations between the clinical presentation and the development of AKI strongly suggest an association between these SPICE preparations and AKI. Further investigations are required to identify the potential nephrotoxic agent(s). Nephrotoxicity from designer drugs should be included in the differential diagnosis of AKI, especially in young adults with negative urine drug screens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23243266      PMCID: PMC3613952          DOI: 10.2215/CJN.05690612

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  7 in total

1.  Myocardial infarction associated with use of the synthetic cannabinoid K2.

Authors:  Arshid Mir; Adebisi Obafemi; Amy Young; Colin Kane
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

2.  The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.

Authors:  Helge Müller; Wolfgang Sperling; Martin Köhrmann; Hagen B Huttner; Johannes Kornhuber; Juan-Manuel Maler
Journal:  Schizophr Res       Date:  2010-01-08       Impact factor: 4.939

3.  Spice: a legal marijuana equivalent.

Authors:  Lucas A Johnson; Rebecca L Johnson; Chris Alfonzo
Journal:  Mil Med       Date:  2011-06       Impact factor: 1.437

4.  Recurrent acute kidney injury following bath salts intoxication.

Authors:  Adedotun Adebamiro; Mark A Perazella
Journal:  Am J Kidney Dis       Date:  2011-11-25       Impact factor: 8.860

5.  A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.

Authors:  Christopher O Hoyte; Jeena Jacob; Andrew A Monte; Mohammed Al-Jumaan; Alvin C Bronstein; Kennon J Heard
Journal:  Ann Emerg Med       Date:  2012-05-09       Impact factor: 5.721

6.  College students and use of K2: an emerging drug of abuse in young persons.

Authors:  Xingdi Hu; Brian A Primack; Tracey E Barnett; Robert L Cook
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-07-11

7.  Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Authors:  Liana Fattore; Walter Fratta
Journal:  Front Behav Neurosci       Date:  2011-09-21       Impact factor: 3.558

  7 in total
  45 in total

1.  Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature.

Authors:  Ayse Sinangil; Vedat Celik; Alev Kockar; Tevfik Ecder
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.

Authors:  Daniel Castellanos; Leonard M Gralnik
Journal:  World J Clin Pediatr       Date:  2016-02-08

3.  Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

Review 4.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

5.  Ischaemic cardiomyopathy and embolic stroke in a young adult with suspected synthetic cannabinoid use.

Authors:  Sumera Khan; Ahmad Hanif; Michael F Wilson
Journal:  BMJ Case Rep       Date:  2018-06-07

Review 6.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

Review 7.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

8.  McArdle disease: a "pediatric" disorder presenting in an adult with acute kidney injury.

Authors:  Xixi Zhao; Angela Li; Madhu Soni; Michael J Muriello; Carolyn H Jones; William L Whittier
Journal:  CEN Case Rep       Date:  2017-06-28

9.  Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis.

Authors:  Francois R Lamy; Raminta Daniulaityte; Ramzi W Nahhas; Monica J Barratt; Alan G Smith; Amit Sheth; Silvia S Martins; Edward W Boyer; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2017-06-01

10.  Convulsant Effects of Abused Synthetic Cannabinoids JWH-018 and 5F-AB-PINACA Are Mediated by Agonist Actions at CB1 Receptors in Mice.

Authors:  Catheryn D Wilson; Sherrica Tai; Laura Ewing; Jasmine Crane; Taylor Lockhart; Ryochi Fujiwara; Anna Radominska-Pandya; William E Fantegrossi
Journal:  J Pharmacol Exp Ther       Date:  2018-11-12       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.